TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03590964

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open sinus lift using chin bone graft
Description: Patients with atrophied posterior maxilla will undergo open sinus lift with chin bone graft according to standardized surgical approach.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sinus lift using bone ring containing the implant.
Description: Patients with atrophied posterior maxilla will undergo sinus lift with chin bone ring containing the implant.
Study: NCT02173509

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multidisciplinary and multifaceted educational intervention.
Description: Outreach visits (40 minutes) which included a PowerPoint presentation and impress materials: poster; flyers; participation certificate and articles mentioned in the presentation. This outreach visit aimed to change the knowledge-attitudes previously identified in a previous study as being associated with poor prescribing of antibiotics in the case of physicians and propensity to dispense antibiotics without medical prescription in the case of pharmacists.
Study: NCT01490905

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Theramine (A medical food)
Description: Theramine two capsules twice daily for 28 days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Theraprofen
Description: Theramine two capsules twice daily and ibuprofen 400mg once daily for 28 days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: Ibuprofen 400mg once daily for 28 days.
Study: NCT01707576

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: consultation 10 days later
Description: new depression screening
Study: NCT02560077

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Subject receive the Placebo product (placebo group had same color and smell of treatment groups)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: cashew apple juice
Description: Subject received the cashew apple juice at dose of 120 mg/day after meal

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: cashew apple juice
Description: Subject received the cashew apple juice at dose of 240 mg/day after meal
Study: NCT00621348

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isotonic fluid
Description: 0.9% saline with 5% dextrose at standard maintenance rate

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hypotonic fluid
Description: Reduced volume (two thirds of standard maintenance rate) of N/5 saline in 5% dextrose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hypotonic fluid
Description: N/5 saline in 5% dextrose at standard maintenance rate
Study: NCT03402464

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Icotinib combined dihydroaremisinin
Description: Icotinib should be taken by the patients continuously until disease progressed or intolerable toxicity. On day 1-3, oral dihydroaremisinin was given at 20mg per day, the dose of dihydroaremisinin is increased to 40mg daily on day 4 to 6, and 80mg twice daily until disease progressed or intolerable toxicity.
Study: NCT03181646

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: citicoline
Description: intravenous citicoline 15 mg per kg per dose BD will be given to babies until oral feeds are established
Study: NCT03671850

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VT-EBV-N
Description: Epstein-barr virus human cytotoxic T lymphocytes (EBV-CTL)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Peripheral blood mononuclear cell, PBMC
Study: NCT01977872

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A worksite activity-diet intervention
Study: NCT00675467

Intervention type: BEHAVIORAL
Intervention: Focus Group - Parent/Caregiver
Description: A 1 1/2 hour group session with other parents/caregivers.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Parent/Caregiver
Description: A 1 1/2 hour group session with other parents/caregivers.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Parent/Caregiver
Description: A 1 1/2 hour group session with other parents/caregivers.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Parent/Caregiver
Description: A 1 1/2 hour group session with other parents/caregivers.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Parent/Caregiver
Description: A 1 1/2 hour group session with other parents/caregivers.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Parent/Caregiver
Description: A 1 1/2 hour group session with other parents/caregivers.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Parent/Caregiver
Description: A 1 1/2 hour group session with other parents/caregivers.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Pediatric Patient
Description: A 1 1/2 hour group session with other pediatric patients.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Pediatric Patient
Description: A 1 1/2 hour group session with other pediatric patients.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Pediatric Patient
Description: A 1 1/2 hour group session with other pediatric patients.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Pediatric Patient
Description: A 1 1/2 hour group session with other pediatric patients.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Pediatric Patient
Description: A 1 1/2 hour group session with other pediatric patients.

Intervention type: BEHAVIORAL
Intervention: Focus Group - Pediatric Patient
Description: A 1 1/2 hour group session with other pediatric patients.
Study: NCT02878980

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise Intervention
Description: Undergo supervised 1-on-1 exercise sessions

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study: NCT00675467

Intervention type: BEHAVIORAL
Intervention: Focus Group - Pediatric Patient
Description: A 1 1/2 hour group session with other pediatric patients.
Study: NCT01275807

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: 10 sessions of acupuncture

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: self care
Description: physical exercice, diet, self help groups, psychological support
Study: NCT03073837

Intervention type: OTHER
Group type: OTHER
Intervention: Rhinovirus Challenge
Description: Challenge with HRV-16 virus
Study: NCT02395432

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: orotracheal intubation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: orotracheal intubation
Study: NCT00606905

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Gamimune N or Gamunex 10%
Description: 500 mg/kg administered in the follicular phase of the menstrual cycle. With conception, infusions every four weeks until 18-20 weeks of gestation.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: equivalent volume of normal saline
Study: NCT04726540

Intervention type: OTHER
Intervention: Patient Satisfaction
Description: Patients were then asked to grade their overdentures/dentures on a visual analog scale and written questionnaire to evaluate their overall satisfaction.

Intervention type: OTHER
Intervention: Patient Satisfaction
Description: Patients were then asked to grade their overdentures/dentures on a visual analog scale and written questionnaire to evaluate their overall satisfaction.
Study: NCT02878980

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT02348515

Intervention type: PROCEDURE
Intervention: Heart failure or coronary disease
Description: Small samples collected from the apex core in the heart. In addition, blood samples will be taken.

Intervention type: PROCEDURE
Intervention: Heart transplant patients
Description: Heart samples collected including, excess myocardial biopsy samples. In addition, blood samples will be taken.

Intervention type: PROCEDURE
Intervention: Orthotopic Heart Transplant Patients
Description: Myocardial tissue samples collected from the diseased heart. In addition, blood samples will be taken.

Intervention type: PROCEDURE
Intervention: Heart Surgery Patients
Description: Heart samples will be collected from the left atrial appendages. In addition, blood samples will be taken.

Intervention type: PROCEDURE
Intervention: Blood Draw
Description: All subjects will have 20 ml of blood drawn for further analysis.

Intervention type: PROCEDURE
Intervention: Blood Draw
Description: All subjects will have 20 ml of blood drawn for further analysis.

Intervention type: PROCEDURE
Intervention: Blood Draw
Description: All subjects will have 20 ml of blood drawn for further analysis.

Intervention type: PROCEDURE
Intervention: Blood Draw
Description: All subjects will have 20 ml of blood drawn for further analysis.
Study: NCT01910675

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCC
Description: 15 IU/kg Octaplex and 2 g Riastab. Additional fibrinogen if needed.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FFP
Description: 4 units Octaplas. Additional fibrinogen if needed.
Study: NCT02851173

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LLLT
Description: The treatment will consist of applying light of a specific wavelength (1064 nm) using a laser diode supplied by Cell Gen Therapeutics, LLC (CG-5000 laser, HD Laser Center, Dallas, TX, USA).

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: The treatment will consist of applying light of a specific wavelength (1064 nm) using a laser diode supplied by Cell Gen Therapeutics, LLC (CG-5000 laser, HD Laser Center, Dallas, TX, USA). However, the placebo group will receive approximately 1/12th of the cumulative energy density as the treatment group.
Study: NCT02531646

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation
Description: Radiation - Each human subject will receive one standard of care x-ray and one Duel Energy exposure or one standard of care x-ray and one Digital Tomosynthesis exposure. Phantoms were imaged using linear tomography and digital tomography.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation
Description: Radiation - Each human subject will receive one standard of care x-ray and one Duel Energy exposure or one standard of care x-ray and one Digital Tomosynthesis exposure. Phantoms were imaged using linear tomography and digital tomography.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation
Description: Radiation - Each human subject will receive one standard of care x-ray and one Duel Energy exposure or one standard of care x-ray and one Digital Tomosynthesis exposure. Phantoms were imaged using linear tomography and digital tomography.
Study: NCT04384081

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 456906
Description: Solution for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 456906
Description: Solution for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 456906
Description: Solution for injection

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Solution for injection
Study: NCT05571566

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Educational Book
Description: An educational book with information about appendicitis for patients, parents and caregivers
Study: NCT00640224

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: rosiglitazone
Description: 4 mg daily for 6 months

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: drospirenone/ethinyl estradiol
Description: 1 tab (3mg/30mcg) daily for 6 months
Study: NCT02948036

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile-device, plasticity-based adaptive cognitive treatment
Description: This study employs a mobile-device delivered treatment program. Participants will be asked to use the assigned treatment program for approximately 30 minutes per session, up to seven sessions per week, over 6 weeks (42 total sessions).
Study: NCT03616808

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Thromboelastometry-guided haemostatic treatment
Description: Administration of blood products and/or procoagulants is based on thromboelastometric assays.
Study: NCT04132271

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalized diet
Description: Modified texture and volumen diet according to the OD specifications

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Nutritional Recommendations according to the OD specifications
Study: NCT01883076

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: autologous cell-based delivery
Description: autologous cells (derived from self)
Study: NCT05944484

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: low caloric diet, ultrasound cavitation,Kegel exercises
Description: * low caloric diet (800-1200) calories/day,). According to each patient, diet contained (carbohydrate protein, fats, minerals, vitamins). 50 to 55% of total calories are carbohydrates, 10 to 15% of total calories protein. Fat limited to less than about 28% of daily total calories .Women took 1200 calories in the first month, 1000 calories in the second month, and 800 calories in the third month. Every week, each woman allowed to change the types of food to avoid boarding.~* ultrasound cavitation emits low-frequency ultrasound 40 khz for 30 minutes on abdomen twice/ week with 3 days apart for 12 weeks.~kegel exercise: Each woman in the study took the same Kegel exercise program performed the Kegel exercise for 12 weeks (3 sessions per week)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: low caloric diet, ultrasound cavitation,Kegel exercises
Description: * low caloric diet (800-1200) calories/day,). According to each patient, diet contained (carbohydrate protein, fats, minerals, vitamins). 50 to 55% of total calories are carbohydrates, 10 to 15% of total calories protein. Fat limited to less than about 28% of daily total calories .Women took 1200 calories in the first month, 1000 calories in the second month, and 800 calories in the third month. Every week, each woman allowed to change the types of food to avoid boarding.~* ultrasound cavitation emits low-frequency ultrasound 40 khz for 30 minutes on abdomen twice/ week with 3 days apart for 12 weeks.~kegel exercise: Each woman in the study took the same Kegel exercise program performed the Kegel exercise for 12 weeks (3 sessions per week)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: low caloric diet, ultrasound cavitation,Kegel exercises
Description: * low caloric diet (800-1200) calories/day,). According to each patient, diet contained (carbohydrate protein, fats, minerals, vitamins). 50 to 55% of total calories are carbohydrates, 10 to 15% of total calories protein. Fat limited to less than about 28% of daily total calories .Women took 1200 calories in the first month, 1000 calories in the second month, and 800 calories in the third month. Every week, each woman allowed to change the types of food to avoid boarding.~* ultrasound cavitation emits low-frequency ultrasound 40 khz for 30 minutes on abdomen twice/ week with 3 days apart for 12 weeks.~kegel exercise: Each woman in the study took the same Kegel exercise program performed the Kegel exercise for 12 weeks (3 sessions per week)
Study: NCT00718653

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lutein
Description: Lutein (12 mg/d)

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lutein plus green tea extract
Description: lutein (12 mg/d) plus green tea extract (200 mg/d)
Study: NCT01787721

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ankle manipulation

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham manipulation
Study: NCT01206088

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nilotinib
Description: administration of nilotinib as 2nd line
Study: NCT03081936

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Oral consumption of Nutricia Aptamil Stage 1 formula
Description: Daily oral consumption of Nutricia Aptamil Stage 1 formula

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral consumption of a2® Platinum Stage 1 formula
Description: Daily oral consumption of a2® Platinum Stage 1 formula

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Oral consumption of breast milk
Description: Daily oral consumption of breast milk
Study: NCT03133741

Intervention type: OTHER
Group type: OTHER
Intervention: GIP-A
Description: GIP-A (GIP receptor antagonist)

Intervention type: OTHER
Group type: OTHER
Intervention: GLP-1 receptor antagonist Exendin[9-39]
Description: Exendin\[9-39\]

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline (9mg/mL)

Intervention type: OTHER
Group type: OTHER
Intervention: GIP-A + Exendin[9-39]
Description: GIP receptor antagonist + GLP-1 receptor antagonist
Study: NCT00947193

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ataluren
Description: Oral powder
Study: NCT03364270

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PET/CT Imaging with [F-18] RGD-K5
Description: PET Imaging/scan with \[F-18\] RGD-K5, PET Imaging/scan with RGD-K5, PET Imaging/scan with K5
Study: NCT00955201

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Structured aerobic exercise (treadmill).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Structured aerobic exercise (treadmill).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Structured isokinetic strength exercise (dynameter).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Structured isokinetic strength exercise (dynameter).
Study: NCT03611257

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: dRAST
Description: Infectious diseases specialists will do active antimicrobial stewardship according to dRAST results in addition to Gram staining results and current standard method.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Current standard method
Description: Infectious diseases specialists will do active antimicrobial stewardship according to Gram staining results, and current standard method without dRAST results.
Study: NCT02824406

Intervention type: DRUG
Intervention: Acetazolamide
Description: Acetazolamide is administered to all participants to induce vasodilation, in order to assess the physiologic response on cerebral blood flow.

Intervention type: DRUG
Intervention: Acetazolamide
Description: Acetazolamide is administered to all participants to induce vasodilation, in order to assess the physiologic response on cerebral blood flow.
Study: NCT02274909

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TRAINING PROGRAM
Description: Sixty healthy elderly women were randomly divided into 3 groups: Pilates group (PG), PNF group (PNFG) and Control group (CG). Pilates and PNF groups underwent one-month training program with Pilates and PNF methods, respectively. CG received no intervention along the one month.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TRAINING PROGRAM
Description: Sixty healthy elderly women were randomly divided into 3 groups: Pilates group (PG), PNF group (PNFG) and Control group (CG). Pilates and PNF groups underwent one-month training program with Pilates and PNF methods, respectively. CG received no intervention along the one month.
Study: NCT01786772

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cryotherapy and compression
Description: Cryotherapy and intermittent pneumatic compression will be applied to the knee joint using a recirculating compression unit and knee sleeve. This unit will recirculate water which is between 1-3° C. Circumferential intermittent pneumatic compression to the knee joint (5 to 50 mm Hg) will be applied in conjunction with cryotherapy. The duration of intervention will be 20 minutes.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cryotherapy
Description: Cryotherapy will be applied to the knee joint using a recirculating compression unit and knee sleeve. This unit will recirculate water which is between 1-3° C. The duration of intervention will be 20 minutes.
Study: NCT03031080

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Thermoplastic Hand Splint
Description: Thermoplastic Night splint created and moulded to the individual patients hand in-house using generic thermoplastic.
Study: NCT02385643

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SmartPhone Support System
Study: NCT03680326

Intervention type: DEVICE
Intervention: OCT
Description: only OCT
Study: NCT04583098

Intervention type: OTHER
Intervention: fecal microbiota transplantation
Description: frozen or capsulized stool from donors who had already finished recommended blood \& stool screening for stool donors

Intervention type: OTHER
Intervention: fecal microbiota transplantation
Description: frozen or capsulized stool from donors who had already finished recommended blood \& stool screening for stool donors
Study: NCT02644109

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Phytosterol
Description: Day 1: Anthropometry, laboratory test, dietary intake (24 hour recall and food frequency questionnaire) and presence of symptoms and side effects will be determined, a logbook will be provided to record product consumption, symptoms, medications and side effects. Then will be randomly assigned to one of the groups.~Days 7 \& 21: 24 hour recall, review of symptoms, side effects and adherence as registered in the logbook.~Days 15 \& 30: Anthropometry, vital signs, venous blood sample, review of symptoms, side effects and adherence to intervention as registered on logbook, dietary intake (24-hour recall), delivery of monetary compensation proportional to the study days will be given before being discharged.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Day 1: Anthropometry, laboratory test, dietary intake (24 hour recall and food frequency questionnaire) and presence of symptoms and side effects will be determined, a logbook will be provided to record product consumption, symptoms, medications and side effects. Then will be randomly assigned to one of the groups.~Days 7 \& 21: 24 hour recall, review of symptoms, side effects and adherence as registered in the logbook.~Days 15 \& 30: Anthropometry, vital signs, venous blood sample, review of symptoms, side effects and adherence to intervention as registered on logbook, dietary intake (24-hour recall), delivery of monetary compensation proportional to the study days will be given before being discharged.
Study: NCT01191762

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sevelamer carbonate
Description: 2400 mg with each meal for 4 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 3 tablets with each meal